Health Centers on the Front Lines Podcast: Status Neutral
Resource updated 10/24/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
Resource (Conference Presentation) updated 09/14/2023
Resource updated 09/19/2023
Resource updated 06/27/2024
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
RWHAP Technical Assistance Provider updated on 07/09/2024
Resource from the RWHAP Best Practices Compilation updated on 11/02/2023
Resource updated 04/03/2024
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
Resource (Conference Presentation) updated 09/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
This presentation will share innovative strategies in the creation of a reflective Consumer Advisory Board, HIT HIV. The presentation will showcase quality improvement projects the HIT HIV CAB completed while leveraging technology, social media, consumer feedback, and CQM principles ensuring a community-driven and equitable process toward ending the HIV epidemic.
Resource (Conference Presentation) updated 09/14/2023